| Literature DB >> 25243059 |
Wilma T Steegenga1, Mona Mischke1, Carolien Lute1, Mark V Boekschoten1, Maurien Gm Pruis2, Agnes Lendvai2, Henkjan J Verkade2, Jos Boekhorst3, Harro M Timmerman3, Torsten Plösch4, Michael Müller5.
Abstract
BACKGROUND: There is increasing appreciation for sexually dimorphic effects, but the molecular mechanisms underlying these effects are only partially understood. In the present study, we explored transcriptomics and epigenetic differences in the small intestine and colon of prepubescent male and female mice. In addition, the microbiota composition of the colonic luminal content has been examined.Entities:
Keywords: Chromosomes; Colon; DNA methylation; Epigenetics; Gene expression; Histone modification; Microbiota; Prepubescent; Sexually dimorphism; Small intestine
Year: 2014 PMID: 25243059 PMCID: PMC4169057 DOI: 10.1186/s13293-014-0011-9
Source DB: PubMed Journal: Biol Sex Differ ISSN: 2042-6410 Impact factor: 5.027
Figure 1Sexually dimorphic gene expression in the SI and colon of 2-week-old C57BL/6 mice. (A) PCA of the top 1,000 most variable genes present in the SI or the colon separates the SI from the colon by PC1 and males from females by PC2. (B) In the SI and the colon, 275 and 86 genes displayed significant (p < 0.01) sexually dimorphic expression, respectively. (C) Four of the significant sexually dimorphic genes revealed male-dominant expression in both the SI and colon while seven genes showed female-dominant expression in both intestinal segments. (D) Expression levels of the seven female-dominant genes in the SI and colon in all individual male and female mice. Correlation between male and female expression levels of the (E) 275 sexually dimorphic genes in the SI and (F) 86 sexually dimorphic genes in the colon. (G) The FC difference between males and females is very low for the majority of the sexually dimorphic genes. Chromosomal localization of the sexually dimorphic genes in the (H) SI and (I) colon relative to the total number of genes localized on each chromosome in the total selection of 10,958 included in the analysis. *p < 0.01, **p < 0.001, ***p < 0.0001.
Top 25 genes displaying the strongest differential expression between males and females in the intestine
| Eif2s3y | −49.68♂ | −46.96♂ | Y | 682 | 21 | Eukaryotic translation initiation factor 2, subU 3, str. gene Y-linked |
| Uty | −48.21♂ | −44.48♂ | Y | 893 | 28 | Ubiquitously transcribed tetratricopeptide repeat gene, Y chr |
| Ddx3y | −28.71♂ | −30.81♂ | Y | 643 | 23 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked |
| Kdm5d | −15.67♂ | −21.58♂ | Y | 757 | 30 | Lysine (K)-specific demethylase 5D |
| Upk1b | −1.12^ | −1.60♂ | 16 | 603 | 11 | Uroplakin 1B |
| Wt1 | −1.02^ | −1.59♂ | 2 | 1282 | 104 | Wilms tumour 1 homologue |
| Syndig1 | −1.52♂ | −1.05^ | 2 | 603 + 1,225 | 3 + 91 | Synapse differentiation inducing 1 |
| Nos2 | 1.09^ | −1.41♂ | 11 | 673 | 8 | Nitric oxide synthase 2, inducible |
| Rab42 | −1.42♂ | −1.17^ | 4 | 783 | 35 | RAB42, member RAS oncogene family |
| Nts§ | −1.41♂ | −1.15^ | 10 | 794 | 6 | Neurotensin |
| Cyp2c66 | 1.45♀ | −1.07^ | 19 | 613 | 1 | Cytochrome P450, family 2, subfamily c, polypeptide 66 |
| Mmp25 | 1.43♀ | 1.05^ | 17 | 893 | 36 | Matrix metallopeptidase 25 |
| Slc7a11§ | 1.40♀ | 1.05^ | 3 | 829 | 18 | Solute carrier family 7, member 11 |
| Nucb2§ | 1.46♀ | 1.07^ | 7 | 666 | 36 | Nucleobindin 2 |
| Alox5ap§ | 1.44♀ | 1.13^ | 5 | 705 | 4 | Arachidonate 5-lipoxygenase-activating protein |
| Gm12696 | −1.13^ | 1.41♀ | 4 | | | Predicted gene 12696 |
| Cabp2 | 1.50♀ | −1.06^ | 19 | 603 + 820 | 3 + 8 | Calcium-binding protein 2 |
| Fkbp11 | 1.56♀ | 1.09^ | 15 | 1041 | 27 | FK506-binding protein 11 |
| Mcpt1 | −1.02^ | 1.54♀ | 14 | 606 | 5 | Mast cell protease 1 |
| Mcpt2 | −1.12^ | 1.66♀ | 14 | 601 | 1 | Mast cell protease 2 |
| Dleu2 | −1.11^ | 1.71♀ | 14 | 798 + 601 | 84 + 45 | Deleted in lymphocytic leukaemia, 2 |
| Ccr3 | 1.59♀ | 1.50^ | 9 | 730 | 3 | Chemokine (C-C motif) receptor 3 |
| Retnl | 1.72♀ | 1.52^ | 16 | 638 | 4 | Resistin-like gamma |
| Kdm6a | 1.59♀ | 1.57♀ | X | 693 + 601 | 51 + 69 | Lysine (K)-specific demethylase 6A |
| Xist | 104.49♀ | 182.91♀ | X | 1,065 | 29 | Inactive X-specific transcripts |
♂Significant ♂-dominant expression FC >1.4.
♀Significant ♀-dominant expression FC >1.4.
^FC without a significant sexually dimorphic effect.
§Previous studies revealed an intestine-specific function and/or expression of this gene.
Figure 2Inter-individual variation in gene expression within the groups of male and female mice. (A) Expression levels of Upkb1, Dleu2, Fkbp11 and Nts in the SI and colon of the individual male and female mice. (B) Hierarchical clustering of the expression levels of the subset of 329 sexually dimorphic genes revealed separation of the males and females in two distinct clusters. *p < 0.01.
Top Bio functions and diseases linked to the sexually dimorphic genes
| SI | | | | | |
| Cellular movement | 8.04E − 14 to 6.18E − 3 | 67 | Inflammatory response | 1.23E − 12 to 6.1E − 3 | 60 |
| Cellular function and maintenance | 5.95E − 11 to 6.1E − 3 | 68 | Hypersensitivity response | 7.04E − 8 to 9.51E − 4 | 24 |
| Cellular compromise | 3.84E − 9 to 2.44E − 3 | 23 | Infectious disease | 6.11E − 5 to 5.59E − 3 | 29 |
| Cell signalling | 2.01E − 8 to 5.71E − 3 | 40 | Hereditary disorder | 1.16E − 4 to 2.78E − 3 | 6 |
| Molecular transport | 2.01E − 8 to 5.71E − 3 | 62 | Inflammatory disease | 1.16E − 4 to 3.29E − 3 | 43 |
| Colon | | | | | |
| Cellular development | 1.12E − 4 to 4.19E − 2 | 19 | Haematological disease | 6.06E − 4 to 3.36E − 2 | 11 |
| Cellular growth and proliferation | 1.12E − 4 to 4.19E − 2 | 23 | Inflammatory response | 1.5E − 3 to 4.19E − 2 | 12 |
| Cell morphology | 1.4E − 4 to 4.31E − 2 | 17 | Cancer | 1.57E − 3 to 4.21E − 2 | 19 |
#mol number of molecules included in the indicated Bio function or disease.
Top networks of sexually dimorphic genes
| SI ♂ vs ♀ | | |
| 1 | Lipid metabolism, small-molecule biochemistry, vitamin and mineral metabolism | 24/41 |
| | ABCG1♀,ALDH1A3♀,ALS2CR12♂,CD300LD♀,CLN8♂,COX6B2♂,CTRC♀,CYP1B1♂,CYP2C19♀,CYP4B1♀,HCK♀,HDAC11♀, | |
| | mir-181♀,MYBL1♂,MYBL2♀,NCAM2♂,PREX1♀,S100A1♂,SELPLG♀,SH3BP1♀,SLC46A3♂,TIFA♂,TOLLIP♂,UBA3♂ | |
| 2 | Lipid metabolism, small-molecule biochemistry, haematological system development and function | 18/28 |
| | ACER3♂,ASAH1♂,BTK♀,CD22♀,LAPTM5♀,NFATC1♀,P2RX7♀,PIK3AP1♀,PIK3CD♀,PLA2G7♀,PLA2G7♀,PLA2G10♀, | |
| | PLCG2♀,PLD2♀,PRR7♀,RASGRP4♀,TNR♂,VPS45♂ | |
| 3 | Haematological system development and function, tissue development, cellular movement | 17/26 |
| | AHR♀,CCL11♀,GNPDA1♂,HCLS1♀,IL15♂,KDM5D♂,KDM6A♀,LAMP1♂,MBD1♂,MZB1♀,P2RX1♀,PLCB2♀,PYGL♀, | |
| | RAC2♀,SRGN♀,TRIM5♂,Uty♂ | |
| 4 | Cell-to-cell signalling and interaction, haematological system development and function, immune cell trafficking | 17/26 |
| | BET1♂,BMP7♂,Ceacam1/Ceacam2♂,DLL4♀,EGF♀,ETS1♀,FXYD5♀,HMGCS1♂,mir-148♂,MMP10♀,PARVG♀, | |
| | RUNX3♀,SAMHD1♀,SH3KBP1♀,SH3PXD2B♂,STAP1♀,TRAM2♂ | |
| Colon ♂ vs ♀ | | |
| 1 | Cardiovascular system development and function, organismal development, tissue morphology | 20/44 |
| | CABP4♂,DDX3X♀,Dleu2♀,DLK1♂,ITGA2B♂,KLK3♀,MAP3K8♂,mir-10♂,mir-181♂,MTCH2♀,NOS2♂,NPR3♂, | |
| | PDGMC♂,PRKCZ♂,PRX♂,STX6♂,SYT9♂,TNMRSM19♂,TNMRSM11B♂,WT1♂ | |
| 2 | Neurological disease, psychological disorders, protein synthesis | 16/33 |
| | BIVm♀,CWC22♀,EIF2S3♂,FUNDC2♀,KDM6A♀,KRT75♂,MED29♂,mir-134♂,PBDC1♀,REEP1♂,RRP12♂,SPTBN2♀, | |
| STAG3♂,SURF6♀,Uty♂,WDR44♀ | ||
Networks with p scores ≥25 are presented.
♂ genes displaying ♂-dominant expression, ♀ genes displaying ♀-dominant expression.
aFocus molecules/score.
Genes displaying sexually dimorphic expression and exhibiting a role in epigenetic processes
| Mbd1 | −1.13♂ | −1.03 | Methyl-CpG-binding domain protein 1 | 18 | Binding to methylated DNA |
| Phf20 | 1.02 | −1.14♂ | PHD finger protein 20 | 2 | Histone acetylation |
| Uty | −48.21♂ | −44.48♂ | Ubiqu. transcribed tetratricopeptide repeat gene, Y chr | Y | Histone demethylation |
| Kdm5d | −15.67♂ | −21.58♂ | Lysine (K)-specific demethylase 5D | Y | Histone demethylation |
| Kdm6a | 1.59♀ | 1.57♀ | Lysine (K)-specific demethylase 6A | X | Histone demethylation |
| Kdm5c | 1.32♀ | 1.28♀ | Lysine (K)-specific demethylase 5C | X | Histone demethylation |
| Bcorl1 | 1.15♀ | 1.04 | BCL6 co-repressor-like 1 | X | Associates with HDAC activity |
| Hdac11 | 1.14♀ | −1.11 | Histone deacetylase 11 | 6 | Histone deacetylation |
| Piwil4 | 1.17♀ | −1.03 | Piwi-like RNA-mediated gene silencing 4 | 9 | Histone methylation |
♂Significant ♂-dominant expression; ♀significant ♀-dominant expression.
Figure 3DNA methylation analysis of the promoter regions of genes displaying sexually dimorphic expression. Significant differential methylation was found in the promoter region of two X-chromosomal genes: (A)Funcd2 and (B)Ddx3x. No differential CpG methylation was found in the promoter region of the autosomal genes (C)Cyp2c66, (D)Alox5ap, (E)Ccr3, (F)Mcpt1, (G)Retnlγ and (H)Nts, all displaying significant sexually dimorphic expression with a FC difference >1.4 between males and females. Blue bars: males; red bars: females. *p < 0.01, **p < 0.001, ***p < 0.0001.
Figure 4Microbiota composition analysis of the colonic luminal content revealed no significant differences between male and female prepubescent mice. (A) Bacteriodetes and Firmicutes dominate the colon lumen in 2-week-old male and female pups. (B) Hierarchical clustering using weighted UniFrac as a distance measure of the male and female mouse pups revealed no clustering of the sexes. (C) RDA plots show microbiota differences based on litter origin, but (D) only marginal and not significant differences were found between male and female mice. Boxplot diagrams of the beta-diversity showed (E) a more distinct difference of the mice of litter 1 compared to litters 2 and 3 but (F) no significant differences between males and females. (G) OTU610 (classified as Syntrophococcus) was identified to being most uniquely associated and hence predictive for the male sex.